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ABSTRACT The neonatal Fc receptor (FcRn) transports
maternal IgG from ingested milk in the gut to the bloodstream
of newborn mammals. An FcRn dimer was observed in crys-
tals of the receptor alone and of an FcRn-Fc complex, but its
biological relevance was unknown. Here we use surface plas-
mon resonance-based biosensor assays to assess the role of
FcRn dimerization in IgG binding. We find high-affinity IgG
binding when FcRn is immobilized on a biosensor chip in an
orientation facilitating dimerization but not when its orien-
tation disrupts dimerization. This result supports a model in
which IgG-induced dimerization of FcRn is relevant for sig-
naling the cell to initiate endocytosis of the IgG-FcRn com-
plex.
Maternal IgG in milk is transported to the bloodstream of
newborn rodents via the neonatal Fc receptor (FcRn) ex-
pressed in the gut (1). FcRn binds to the Fc portion of IgG at
the pH of milk in the gut (pH 6.0-6.5). Upon binding, the
FcRn-IgG complex is endocytosed and then transcytosed to
the basolateral side of the cell, which faces the bloodstream.
The slightly basic pH of blood (pH 7.5) causes IgG to
dissociate from FcRn (2), thereby releasing maternal antibody
in the bloodstream of the neonate and enabling the newborn
to passively acquire immunity to antigens encountered by the
mother. A human homolog mediates the transfer of maternal
IgG across the placenta (3). FcRn resembles class I major
histocompatibility complex (MHC) molecules (4, 5), which
present peptide antigens to T cells (6). Both FcRn and class I
molecules consist of a membrane-spanning heavy chain with
three extracellular domains, al, a2, and a3, that are nonco-
valently attached to a soluble light chain, 32-microglobulin
(f2m) (7). The recently determined crystal structure of FcRn
verified its structural similarity to class I MHC molecules and
revealed an FcRn dimer of heterodimers (hereafter referred to
as the FcRn dimer) mediated by contacts between the a3 and
f32m domains (8). The existence of the FcRn dimer on a
membrane requires a "lying down" orientation of the receptors
with their long axes nearly parallel to the plane of the
membrane (Fig. 1A), by contrast to the "standing up" orien-
tation generally assumed for class I MHC molecules, which are
not observed to form dimers or other oligomers. Because of
the 2:1 binding stoichiometry between FcRn and IgG (10), and
because soluble FcRn is predominantly monomeric in solution
(11), we previously suggested that the FcRn dimer could
represent a receptor dimer induced by IgG binding (8) and
assumed that the dimer could form in the absence of IgG in the
FcRn crystals because of the high protein concentrations
required for crystallization. The oligomeric state of the recep-
tor on the membrane is unknown.
The same FcRn dimer was found in the low-resolution
crystal structure of an FcRn-Fc complex (9), supporting the
suggestion that FcRn dimers bind IgG on cell surfaces in a lying
down orientation. However, the interpretation of the FcRn-Fc
crystal structure is complicated by the packing in the cocrys-
tals, which creates two distinct 2:1 complexes, only one of
which incorporates the FcRn dimer. In the first 2:1 complex
(the lying down complex; Fig. 1A), Fc contacts the FcRn dimer
asymmetrically, so that most of the predicted contacts to Fc
involve only one molecule of the FcRn dimer. An attractive
feature of the lying down complex is that a signal for endo-
cytosis of the FcRn-IgG complex could be binding of an IgG
to one receptor, followed by recruitment of a second FcRn to
form a receptor dimer in which the cytoplasmic domains are
brought into spatial proximity. The second 2:1 complex (the
standing up complex; Fig. 1B) does not involve the receptor
dimer, and there is no contact between the two receptors upon
binding Fc. Instead, Fc binds symmetrically between two FcRn
molecules that are oriented with their long axes perpendicular
to membrane. We previously used the results of mutagenesis
studies (12) and steric considerations to argue that the 2:1
complex involving the FcRn dimer (the lying down complex)
is relevant for binding of intact IgG at the cell surface (9).
However, since most of the predicted FcRn contacts to Fc in
the lying down complex involve only one molecule of the FcRn
dimer (9), the contribution of the other FcRn molecule in the
dimer to the overall affinity of the FcRn-IgG interaction was
unclear. Here we used oriented coupling to a biosensor chip
and a surface plasmon resonance (SPR) assay (13, 14) to
investigate the relative affinities of FcRn molecules in which
dimerization was facilitated and FcRn molecules in which
dimerization was hindered. We present evidence that the FcRn
dimer is required for high-affinity binding of IgG, thereby
implying that FcRn dimerization is crucial for IgG binding at
the cell surface and providing further support for existence of
the lying down 2:1 FcRn-IgG complex. These results raise the
possibility that FcRn may function like many other cell surface
receptors in which ligand-induced dimerization is the primary
event required for downstream signal transduction (15).
MATERIALS AND METHODS
Reagents. Iodoacetyl-LC-biotin (N-iodoacetyl-N-biotinyl-
hexylenediamine) was obtained from Pierce. Rabbit anti-
human f32m and peroxidase-conjugated anti-rabbit antibodies
for ELISAs were from Boehringer Mannheim. N-Ethyl-N'-(3-
diethylaminopropyl)carbodiimide, N-hydroxysuccinimide,
2-(2-pyridinyldithio)ethaneamine, ethanolamine, BIAcore
surfactant P20, certified CM5 sensor chips, and streptavidin-
coated sensor chips were from Pharmacia Biosensor. Murine
IgGl was purchased from PharMingen.
Abbreviations: 132m, 132-microglobulin; FcRn, Fc receptor, neonatal;
MHC, major histocompatibility complex; RU, resonance units; SPR,
surface plasmon resonance.
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FIG. 1. Free thiols introduced into FcRn for oriented coupling
highlighted on ribbon diagrams of the two different 2:1 FcRn-Fc
complexes observed in cocrystals of FcRn and Fc (9). For cell surface
FcRn, the membrane is assumed to be horizontal in each figure. The
FcRn heavy chain is green, I32m is light blue, Fc is dark blue, disulfide
bonds are yellow, and introduced Cys residues are purple (FcRn D)
and red (FcRn M). (A) Cys mutations highlighted on the lying down
2:1 complex of FcRn and Fc. Coupling of FcRn D (Cys introduced at
32m residue 19; purple; 25-30 A from the approximate center of the
FcRn dimerization interface) to the biosensor chip is predicted to
facilitate formation of the FcRn dimer, allowing formation of this 2:1
complex. Coupling of FcRn M (Cys introduced at the FcRn dimer
interface at FcRn heavy chain residue 191; red) to the biosensor chip
is predicted to hinder formation of the FcRn dimer, so that formation
of this 2:1 complex would be impaired on the surface of the biosensor
chip. (B) Cys mutations highlighted on the standing up 2:1 complex of
FcRn and Fc that does not involve FcRn dimerization. If FcRn dimers
are not involved in binding of IgG, there should be minimal or no
effects of coupling via either of the introduced Cys residues.
Expression of Mutant FcRn Molecules. The cDNA encod-
ing the truncated FcRn heavy chain was first altered by
oligonucleotide-directed in vitro mutagenesis (16) to remove
free sulfydryl groups that would interfere with coupling via
introduced Cys residues (Cys-48 and Cys-226 were changed to
Ser). For FcRn M, an additional mutation was introduced in
the heavy chain gene to change Gly-191 to Cys. For FcRn D,
a mutation was introduced into the cDNA encoding /2m to
change Lys-19 to Cys. After verifying the sequence of the
altered cDNAs, the mutant heavy chain gene was subcloned
into the expression vector pBJ5-GS (11), and the mutant light
chain gene was subcloned into the expression vector pBJ1 (17).
Cotransfection of FcRn and j32m expression vectors into
Chinese hamster ovary (CHO) cells and selection using the
drug methionine sulfoximine were carried out as described
(12). Cell supernatants were screened for protein expression by
a sandwich ELISA, using the FcRn-specific monoclonal anti-
body 1G3 (12) as the capture antibody and a polyclonal
antiserum against human j32m to detect positive samples as
described (18). Results were verified by immunoprecipitations
with the 1G3 antibody. The highest expressing clones for FcRn
D and M were grown in fifty 10-cm tissue culture plates, and
the mutant proteins were purified from the supernatants by
pH-dependent binding to a rat IgG column (11).
SPR-Based Biosensor Experiments. A BIAcore biosensor
system (Pharmacia LKB Biotechnology) was used to measure
FcRn-IgG binding interactions. This system includes a bio-
sensor chip that has a gold surface coated with flexible dextran
linkers to which biomolecules can be coupled. Binding inter-
actions between the coupled molecules and a second molecule
injected over the chip surface result in changes in the SPR
signal that are read out in real time as resonance units (RU)
(13, 14). RU values above 50 were considered significant. The
derived data is in the form of sensorgrams (plots of RU versus
time), which can be analyzed to estimate association and
dissociation kinetics and binding constants. In the first set of
experiments, IgG [M1/42, a rat IgG2a purified as described
(12)] was immobilized to a biosensor chip surface using
standard amine coupling chemistry (12), and different con-
centrations of FcRn D or M were injected over the IgG-
coupled biosensor element. In the second set of experiments,
FcRn D or M was immobilized using thiol chemistry as
described below, and different concentrations of murine IgGl
were injected. In a third set of experiments, biotinylated FcRn
D and M were immobilized on a streptavidin-coated sensor
chip, and different concentrations of murine IgGl were in-
jected. Rat IgG2a was used in the first set of experiments
rather than the murine IgGl used in the second and third sets
of experiments because the activity of murine IgGl was found
to be significantly affected by amine-based coupling. Flow
rates of 5 ,ul/min were used for all of the experiments. Sensor
chip surfaces were regenerated by injecting a pulse of 50 mM
phosphate/150 mM NaCl, pH 7.5.
Thiol Coupling of FcRn to Biosensor Chips. FcRn M or D
was incubated on ice for 3-4 hr with 20 mM cysteine HCl/20
mM NaHCO3. Free cysteine was removed by two sequential
centrifugations through Bio-Spin 30 chromatography columns
(Bio-Rad) equilibrated in 10 mM citrate buffer (pH 4.0). The
proteins were further diluted in the citrate buffer to a con-
centration of 25-50 ,ug/ml and immobilized by initial activa-
tion of the sensor chip with 0.05 M N-hydroxysuccinimide and
0.2 M N-ethyl-N'-(3-diethylaminopropyl)carbodiimide, fol-
lowed by reaction with 80 mM 2-(2-pyridinyldithio)ethaneam-
ine in 100 mM borate buffer (pH 8.5), and then injection of
FcRn M or D. Excess reactive groups were deactivated by
injecting 50 mM L-cysteine/1.0 M NaCl in 100 mM sodium
formate buffer (pH 4.3).
Stoichiometry Measurements. Stoichiometries of FcRn-
IgG complexes were calculated as described in the BIAcore
methods manual. After immobilization of FcRn, the net SPR
signals (the RU value 10-15 sec after the start of the disso-
ciation phase) were recorded for IgG injections at concentra-
tions between 15 and 20 ,uM. The equation
S = [RU(IgG)/RU(FcRn)I
x [molecular weight(FcRn)/molecular weight(IgG)]
was used to calculate s, the number of IgG molecules that bind
per FcRn molecule.
Biotinylation of FcRn. FcRn D and FcRn M were biotin-
ylated on the introduced Cys residue using iodoacetyl-LC-
biotin. For this purpose, FcRn D or FcRn M protein in 50 mM
Tris/5 mM EDTA, pH 8.3, was treated in the dark for 90 min
with 0.9 molar equivalent of iodoacetyl-LC-biotin dissolved in
dimethyl sulfoxide. The mixtures were subsequently chromato-
graphed over a small gel-filtration column to remove excess
biotin reagent.
Affinity Measurements of FcRn-IgG Complexes and Anal-
ysis of Dissociation Rates. High-affinity binding constants
were calculated from estimates of the kinetic constants by
nonlinear analysis of the association and dissociation curves
using the BIAEVALUATION 2.0 software package. Binding con-
stants (Table 1) were calculated assuming a single averaged
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association rate constant and a single averaged dissociation
rate constant. A detailed analysis of the dissociation curves
(see below) shows the existence of high- and low-affinity
populations; however, the high-affinity population predomi-
nates (>80%) over the concentration ranges used in these sets
of experiments. The reported binding constants are therefore
representative of the high-affinity population.
The dissociation phase of the sensorgrams was analyzed in
detail for the binding of murine IgGl to FcRn D or M
immobilized directly via the respective thiol residues or via the
biotin linker (Table 2). The BIAEVALUATON 2.0 software pack-
age was used to first fit the experimental dissociation curves to
a single-exponential dissociation rate equation (y = Re-kdt,
where kd is the rate constant and R corresponds to the RU
value at the start of the dissociation analysis). The experimen-
tal dissociation curves were next fit using a two-exponential
dissociation rate equation [y = Rfast e-kd(faSt)t + Rslow e-kd(SIOw)t,
where kd(slw) and kd(fast) represent fast and slow rate constants,
and Rsi0w and Rfast correspond to the fraction of complexes
dissociating with each rate constant]. Using the BIAEVALUA-
TION 2.0 software, an F test based comparison between derived
X2 values for the single-exponential or two-exponential fits
yielded an estimated probability that the second model is
better than the first. In every case for which we report two kd
values, [kd(slow) and kd(fast); Table 2], the probability that the
two-exponential dissociation model fit the experimental dis-
sociation data better than a single-exponential model was in
the range of 0.99-1.0.
RESULTS
The Effects of FcRn Orientation upon Affinity for IgG. Two
mutant forms of soluble FcRn heterodimers [residues 1-269 of
the rat FcRn heavy chain complexed with rat j32m (11)] were
generated to facilitate thiol coupling of FcRn on a biosensor
chip in two defined orientations. Free sulfydryl residues were
first removed from the FcRn heavy chain using site-directed
mutagenesis (16) to change Cys-48 and Cys-226 to Ser residues.
A Cys was then introduced at residue 19 of rat f32m to make
the FcRn D mutant (/32m Lysl9Cys) or at residue 191 of the
FcRn heavy chain to make FcRn M (Glyl9lCys). None of the
residues that were changed in FcRn D or FcRn M are close to
or at the predicted IgG binding interface deduced from the
crystal structure of the FcRn-Fc complex (9); therefore, the
modifications should not directly interfere with IgG binding
(Fig. 1). Mutant proteins were purified from transfected cell
supernatants by pH-dependent binding to a rat IgG column
(11), thus verifying that the mutations did not significantly
affect the interaction between FcRn and IgG. As further
characterization of the mutants, IgG binding by both mutant
receptors was characterized by coupling a rat IgG molecule on
a biosensor chip and injecting either FcRn M or FcRn D
proteins at pH 6.0 (Fig. 2A and B). Comparisons of the derived
affinities reveal only minor differences in IgG binding by either
FcRn M or FcRn D (Table 1). Next, thiol chemistry was used
to couple FcRn M or FcRn D to biosensor chips to evaluate
the effects of FcRn orientation upon IgG binding. For these
experiments, the FcRn molecules were coupled to a biosensor
chip surface to a density of 2000-2200 RU, which should
permit dimerization of the coupled receptors, since a coupling
density of FcRn molecules of 2000 RU corresponds to 2.0
ng/mm2 or two molecules per 104 2 (100 A x 100 A).
Coupling of FcRn D to a biosensor chip via the engineered
Cys-19 of f32m is predicted to promote the formation of the
crystallographically observed FcRn dimer on the surface of the
chip (Fig. 1A). Indeed, when high concentrations of IgG are
injected (15-20 ,uM), we calculate a stoichiometry of 0.3-0.5
IgG per immobilized FcRn D (see Materials and Methods).
Coupling of FcRn M via the introduced Cys at residue 191 of
the FcRn heavy chain, which is located within the FcRn dimer
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FIG. 2. SPR assays of the interaction between FcRn D or FcRn M
with IgG. Observed RU are plotted as a function of time (sensor-
grams) in each panel. Sensor chip surfaces were regenerated between
different injections by injecting a pulse of 50 mM phosphate/150 mM
NaCl, pH 7.5. (A andB) FcRn D or FcRnM samples were injected over
rat IgG2a immobilized on a biosensor chip to a final response of 1640
RU (1.6 ng/mm2) using amine coupling chemistry. Two injections
corresponding to 1 ,uM and 2 ,uM FcRn D (A) and FcRn M (B) were
performed. (C and D) FcRn D and FcRn M were immobilized on
different flow cells of the same biosensor chip using thiol coupling
chemistry. Four different concentrations of murine IgGl (530 nM to
4.3 ,uM) were injected over FcRn D coupled to a density of 2200 RU
(2.2 ng/mm2) (C) or FcRn M coupled to a density of 2000 RU (2.0
ng/mm2) (D) or over a blank flow cell (data not shown). For FcRn M,
a net positive SPR signal >50 RU is seen only when the concentration
of injected IgG is >4 ALM. (E and F) Biotinylated FcRn D and FcRn
M were injected over different flow cells of a commercially available
streptavidin-coated sensor chip. Four different concentrations of
murine IgGl (375 nM to 3 ,uM) were injected over FcRn D coupled
to a density of 1200 RU (1.2 ng/mm2) (E) or FcRn M coupled to a
density of 1750 RU (1.75 ng/mm2) (F).
interface (Fig. 1A) (8), should disrupt formation of the FcRn
dimer because the molecules would be tethered at their
dimerization site to the dextran matrix of the biosensor chip.
IgG binding by immobilized FcRn M is markedly impaired
compared to FcRn D (Table 1 and Fig. 2 C and D). It is not
possible to estimate a stoichiometry for the FcRn M-IgG
interaction, since very high IgG concentrations would be
required to observe saturation. Fig. 2 C and D compares the
binding at pH 6.0 of different concentrations of a murine IgG
injected over immobilized FcRn D or immobilized FcRn M.
The estimated affinity of FcRn M for IgG is at least 100-fold
lower than the affinity of FcRn D for IgG (Table 1). Because
only small affinity differences were observed between the two
forms of FcRn when binding to immobilized IgG (Fig. 2A and
B; Table 1), these results suggest that the marked impairment
of IgG binding when FcRn M is coupled to the chip is a direct
consequence of its orientation on the chip surface rather than
an effect of the introduced mutations.
Impaired IgG binding by immobilized FcRn M can be
prevented by incorporating a long linker arm between thiol
Proc. Natl. Acad. Sci. USA 92 (1995)
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Table 1. Effects of FcRn orientation upon affinity for IgG:
Comparison of the affinities of FcRn M-IgG and FcRn D-
IgG complexes
Ratio of
Kd, nM Kd values
FcRn M/
Experiment FcRn M FcRn D FcRn D
IgG immobilized 240.0 ± 50.3 80.2 ± 26.7 3.0
FcRn immobilized >4000 22.0 ± 4.5 >100
by direct thiol
coupling
FcRn immobilized 189.0 ± 34.9 103.5 ± 11.1 1.8
via biotin linker
For the IgG immobilized experiments, a rat monoclonal IgG2a
antibody was immobilized to a final response of 1640 RU, and FcRn
D or FcRn M was injected. For FcRn immobilized by direct thiol
coupling, mutant FcRn molecules were coupled via introduced Cys
residues to densities of 2200 RU (FcRn D) and 2000 RU (FcRn M)
and a murine IgGl was injected. For FcRn immobilized via biotin
linker, FcRn M or FcRn D was coupled -20 A from the biosensor
surface to densities of 1750 and 1200 RU, respectively, and murine
IgGl was injected. Under conditions where FcRnM is directly coupled
to the chip surface, there is no specific binding observed at IgG
concentrations below 4 ,uM, suggesting a micromolar (or weaker)
affinity constant for the interaction. The absolute values of the
high-affinity Kd values determined for FcRn D under the three
different experimental conditions vary 4- to 5-fold, representing the
level of experimental error introduced by different coupling methods
or the use of different chips and/or varying affinities of FcRn for
different IgGs.
residue 191 and the surface of the biosensor chip. If the free
thiol groups on FcRn D or M are derivatized with iodoacetyl-
LC-biotin and subsequently coupled to avidin immobilized on
a biosensor chip, thus allowing more than a 20 A spacer
between the respective thiol groups and the surface of the chip,
the affinities and dissociation rate properties for IgG binding
by FcRn M and FcRn D are very similar (Fig. 2E and F; Tables
1 and 2). In addition, the calculated stoichiometry of the
FcRn-IgG interaction is 0.5 IgG per FcRn M or FcRn D
immobilized via the biotin linker. These results suggest that
FcRn can form dimers when a narrow linker group is attached
to cysteine residues at the dimerization interface, provided
there is sufficient room above the surface of the biosensor chip
to allow the two molecules to come together. When tethered
directly to the chip, as in the experiment depicted in Fig. 2D,
the dimerization interface is expected to be much less acces-
sible.
Comparison of Observed Dissociation Rate Constants (kd)
and Net SPR Signals (Rt) of FcRn D-IgG and FcRn M-IgG
Complexes as a Function of IgG Concentration and FcRn
Coupling Density. Biphasic binding curves have previously
been observed for the interaction of IgG with FcRn in brush
border membrane extracts from neonatal rats, suggesting the
existence of two populations of FcRn with differing affinities
for IgG (19). Consistent with this observation, we find that the
assumption of two populations of complexes with fast and slow
dissociation rate constants (see Materials and Methods and
Table 2) approximates the BlAcore experimental data better
than the assumption of a single homogeneously dissociating
population. The hypothesis that the slow dissociating species
corresponds to a high-affinity 2:1 FcRn-IgG complex and the
fast dissociating species corresponds to a low-affinity 1:1
FcRn-IgG complex is supported by the following trends
deduced from the data in Table 2. (i) For a given coupling
density of FcRn on the surface of the chip, the fast dissociating
species becomes more predominant at high IgG concentra-
tions, which are expected to drive the formation of 1:1
FcRn-IgG complexes. (ii) For a given IgG concentration, as
the coupling density of FcRn is increased (facilitating FcRn
dimerization), the slow dissociating species becomes more
predominant.
With the assumption that the slow dissociating species
corresponds to a high-affinity 2:1 FcRn-IgG complex and the
fast dissociating species corresponds to a lower affinity 1:1
FcRn-IgG complex, the data presented in Table 2 demon-
strate the impairment of dimerization of immobilized FcRn M
compared to FcRn D. For example, when a low density
(2000-2900 RU) of FcRn M molecules is coupled to the chip,
Table 2. Comparison of observed rate constants (kd) and net SPR signals (Rt) of FcRn D-IgG and FcRn M-IgG
complexes as a function of IgG concentration and FcRn coupling density
Coupling kd(fast)
density, kd(slow) X 103,
Coupled molecule RU x 103, S-1 s-i IgG, ,uM Rt, RU % slow % fast
FcRn D 2200 1.7 ± 0.3 24 ± 7 0.13 860 88.6 11.4
17.17 1480 83.0 17.0
FcRn M 2000 - 31 ± 3 4.29 60 0 100
17.17 110 0 100
FcRn M 2900 3.8 ± 0.4 39 ± 6 0.58 70 44.6 55.4
18.67 200 38.6 61.4
FcRn D 5400 1.9 ± 0.3 43 ± 16 0.15 1060 100 0
9.33 2320 88.3 11.7
FcRn M 6600 2.8 ± 0.4 29 ± 10 0.15 380 87.3 12.7
9.33 1120 78.7 21.3
Biotin M 1750 1.6 ± 0.2 18 ± 2 0.38 513 89.7 10.3
3.00 817 71.8 28.2
Biotin D 1200 1.7 ± 0.8 27 ± 3 0.38 439 92.4 7.6
3.00 641 84.0 16.0
FcRn M and FcRn D were coupled via their introduced Cys residues to the specified densities using a direct thiol coupling
protocol or via a biotin linker (biotin D and biotin M). Various concentrations of murine IgGl were injected within the specified
concentration ranges. In order to disregard contributions to the SPR signal from buffer differences and nonspecific binding,
the net signal observed is presented at each concentration of injected IgG as Rt, the RU value 10-15 sec after the start of the
dissociation phase. Rt values above 50 RU were considered significant. kd(slow) and kd(fast) represent derived fast and slow rate
constants (see Materials and Methods) and % slow and % fast correspond to RSIOW and Rfast (the fraction of Rt dissociating with
the two respective rate constants). The fast and slow rate constants are presumed to correspond to 1:1 (low affinity) and 2:1
(high affinity) FcRn-IgG complexes, respectively (see text). When FcRn M is coupled to the chip at low densities (2000-3000
RU), most of the FcRn M-IgG complexes show fast dissociation rates (a low-affinity interaction), and high IgG concentrations
are required to observe significant Rt values, illustrating impaired IgG binding by FcRn M.
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either none of the FcRn M-IgG complexes or only a minority
population show the slow dissociation rate, and high IgG
concentrations are required to observe a net positive SPR
signal (Rt). By contrast, at a similar coupling density, the
majority of FcRn D molecules form high-affinity complexes
with IgG that show the slow dissociation rate, and the net SPR
signal is large. When a high density (6600 RU) of FcRn M
molecules is coupled to the chip, high-affinity binding of FcRn
M is not completely inhibited. However, only a fraction of the
total FcRn M molecules are able to bind with high affinity, as
suggested by the significantly lower net SPR signals obtained
for FcRn M compared to FcRn D.
DISCUSSION
When a low density of FcRn M is coupled to the chip, no net
equilibrium responses are observed when IgG is injected at
concentrations below 4 ,uM, suggesting that the affinity con-
stant for IgG binding under conditions where FcRn dimeriza-
tion is nearly completely prevented is micromolar or weaker.
In contrast, for FcRn D-IgG complexes, the high-affinity
binding constant is 22.0 ± 4.5 nM (Table 1 and Fig. 2C). This
binding constant is consistent with previous estimates derived
from analyses of IgG binding to cell surface FcRn (12, 19),
which implies that FcRn dimerizes at the cell surface when IgG
is bound. The affinity loss from impaired dimerization is thus
estimated to be >100-fold. A comparable loss in affinity
between FcRn and IgG occurs as the pH is raised from 6.0 to
7.0 (22). The question therefore arises of whether the forma-
tion and disruption of the FcRn dimer could account for the
sharply pH-dependent interaction with IgG. Imidazole side
chains of histidine residues usually deprotonate over the pH
range of 6.0-7.0; therefore, histidine residues at the FcRn
dimer interface could bring about a pH-dependent destabili-
zation of the dimer by the neutralization of positive charges
above the pKa values of the histidine residues. Two histidine
residues are located at the FcRn dimer interface: residues 250
and 251 in the a3 domain of the FcRn heavy chain. Previous
mutagenesis studies of the histidine pair showed that alteration
of these residues resulted in a mutant FcRn molecule with
-6-fold reduced affinity for IgG (12). Because these residues
do not contact Fc directly (9), their effect on the affinity of
FcRn for IgG must be due to participation in FcRn dimer
formation. Titration of one or both residues of the histidine
pair in wild-type FcRn could indirectly affect its affinity for
IgG by stabilizing the FcRn dimer at pH 6.0-6.5 (permissive
for IgG binding) and destabilizing the FcRn dimer at pH values
above 7.0-7.5 (nonpermissive for IgG binding), thereby pro-
viding a mechanism to partially account for the pH-dependent
alteration of the FcRn-IgG affinity. Other mechanisms such as
titration of histidine residues at the IgG-FcRn interface must
also contribute to the overall affinity transition, since the
histidine pair mutant binds IgG in a pH-dependent manner
(12).
In summary, we have demonstrated that the binding of IgG
to FcRn is strongly influenced by the orientation of FcRn on
the surface of a biosensor chip. The methods described here
should be generally applicable to assess the importance of
receptor oligomerization for the many other receptors that
dimerize in response to ligand binding and for investigating the
functional significance of higher order structures sometimes
observed in crystallographic analyses-e.g., the crystallo-
graphically observed dimer of class II MHC molecules (20).
Similar methods have been used to study a 1:1 human growth
hormone-hormone receptor complex, a complex that nor-
mally shows 2:1 receptor to hormone stoichiometry due to
hormone-induced receptor dimerization (21). The results pre-
sented here provide strong evidence that the crystallographi-
cally observed FcRn dimer of heterodimers is necessary for
high-affinity IgG binding and directly support the existence of
the lying down 2:1 FcRn-IgG complex (Fig. 1A) at the cell
surface. The formation of both lying down and standing up
complexes is possible in the event that two adjacent mem-
branes are sufficiently close to allow formation of networks of
FcRn-IgG complexes consisting of lying down FcRn dimers
bridged by IgG (9). Parallel adjacent membranes exist in the
microvilli of brush borders of intestinal epithelial cells, where
FcRn is expressed and functions (1). Thus, although the data
presented in this paper strongly support the hypothesis that
FcRn dimerization is required for high-affinity binding of IgG,
the interactions that form the standing up 2:1 complex may
have some physiological relevance.
A Kd in the micromolar range for the dimerization-impaired
FcRn, compared to a nanomolar Kd for dimerization-
competent FcRn, is surprising in light of the crystal structure
of the FcRn-Fc complex (9), which shows only a few contacts
between Fc and the second molecule of the FcRn dimer.
However, FcRn dimerization could alter its conformation so as
to enhance the IgG binding affinity. If dimeric FcRn molecules
do not preexist at the cell surface but are induced by IgG
binding, FcRn dimerization could serve as a signal for the
initiation of endocytosis of FcRn-IgG complexes, by analogy
to activation of many growth factor and cytokine receptors by
ligand-induced dimerization (15).
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